Jane Street
XENE icon

Jane Street’s Xenon Pharmaceuticals XENE Stock Holding History

Jane Street’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,468
Closed -$193K – 13322
2026
Q1 		$202K Buy
+3,468
New +$160K ﹤0.01% 10131
2025
Q4 		– Sell
-89,879
Closed -$3.77M – 12570
2025
Q3 		$3.61M Buy
89,879
+46,203
+106% +$1.63M ﹤0.01% 3920
2025
Q2 		$1.37M Buy
+43,676
New +$1.42M ﹤0.01% 5054
2025
Q1 		– Sell
-11,138
Closed -$423K – 10790
2024
Q4 		$437K Buy
+11,138
New +$461K ﹤0.01% 7061
2024
Q3 		– Sell
-14,755
Closed -$595K – 10513
2024
Q2 		$575K Buy
14,755
+6,306
+75% +$252K ﹤0.01% 6784
2024
Q1 		$364K Sell
8,449
-20,941
-71% -$963K ﹤0.01% 7243
2023
Q4 		$1.35M Buy
29,390
+4,911
+20% +$174K ﹤0.01% 5021
2023
Q3 		$836K Buy
24,479
+15,762
+181% +$590K ﹤0.01% 5463
2023
Q2 		$336K Buy
8,717
+3,051
+54% +$121K ﹤0.01% 6947
2023
Q1 		$203K Sell
5,666
-9,624
-63% -$356K ﹤0.01% 7824
2022
Q4 		$603K Sell
15,290
-26,622
-64% -$969K ﹤0.01% 5812
2022
Q3 		$1.51M Buy
+41,912
New +$1.51M ﹤0.01% 4671
2022
Q2 		– Sell
-16,117
Closed -$487K – 11060
2022
Q1 		$493K Buy
+16,117
New +$482K ﹤0.01% 7519

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Jane Street's XENE Position: Q2 2026 in Review

Jane Street sold out of Xenon Pharmaceuticals (XENE) in Q2 2026, closing a stake of 3,468 shares — an estimated $193K sold.

Jane Street first reported a position in XENE in Q1 2022 and held it in 13 quarters. The position peaked at $3.61M in Q3 2025. 315 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • Jane Street reported no remaining Xenon Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 3,468 Xenon Pharmaceuticals shares in Q2 2026, an estimated $193K.
  • Jane Street first reported a position in Xenon Pharmaceuticals in Q1 2022 and held it in 13 quarters.
  • Jane Street's Xenon Pharmaceuticals position peaked at $3.61M in Q3 2025.
  • 315 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.